🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.5 tsp Serving Size
340 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

2 Gram(s)
📊 Market median: 800.0mg (172 products)
Median 800.0mg This product: 2mg

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (84% of products) Nutrient (26% of products) No Claim (1% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Suggested Usage: Adults: Take 1 teaspoon (1/3 scoop) daily. Advanced Use: Take 1 rounded scoop daily, 30-45 minutes before exercise. Children (6-12 yrs.): Take 1/2 to 1 teaspoon daily. May be mixed with food and beverages.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Contains milk.

🧪 Formulation Notes

Contains milk.

This product contains NO yeast, wheat, gluten, soy, corn, sodium, sugar, starch, artificial coloring, artificial preservatives, artificial flavoring, or genetically modified organisms (GMOs).

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity).

Formula #57650P

100% Pure New Zealand

Powder

Product Details

UPC / SKU 3 10539 04061 4
DSLD Entry Date 2016-02-23
Product Type Non-Nutrient/Non-Botanical
Form Powder
DSLD ID 56527
Data Updated 2026-04-11

Research Evidence

19 Research Sources
52 Avg Quality Score
8 Clinical Trial
4 Cochrane Review
2 Systematic Review
2 Meta Analysis
2 Guideline
1 Rct
B [Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
Guideline Zhonghua er ke za zhi = Chinese journal of pediatrics 2025
B Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
Guideline Kidney international 2025
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews
C Intravenous immunoglobulin for myasthenia gravis
Systematic Review The Cochrane database of systematic reviews 2003
C Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
Rct Journal of medicinal food 2016
C Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
Meta Analysis Thyroid : official journal of the American Thyroid Association 2018
C Retinol-to-Fat Ratio and Retinol Concentration in Human Milk Show Similar Time Trends and Associations with Maternal Factors at the Population Level: A Systematic Review and Meta-Analysis
Meta Analysis Advances in nutrition (Bethesda, Md.) 2018
View all evidence for Colostrum →

Compare Similar Products

View all Colostrum products →